Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients-Reference-Cited by-同舟云学术

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

Published:2022-02-10 Issue:6 Volume:386 Page:509-520
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Jayk Bernal Angélica¹,Gomes da Silva Monica M.¹,Musungaie Dany B.¹,Kovalchuk Evgeniy¹,Gonzalez Antonio¹,Delos Reyes Virginia¹,Martín-Quirós Alejandro¹,Caraco Yoseph¹,Williams-Diaz Angela¹,Brown Michelle L.¹,Du Jiejun¹,Pedley Alison¹,Assaid Christopher¹,Strizki Julie¹,Grobler Jay A.¹,Shamsuddin Hala H.¹,Tipping Robert¹,Wan Hong¹,Paschke Amanda¹,Butterton Joan R.¹,Johnson Matthew G.¹,De Anda Carisa¹

Affiliation:

1. From IMAT Oncomédica, Monteria, Colombia (A.J.B.); the Department of Public Health, Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil (M.M.G.S.); Jongaie Research, Pretoria, South Africa (D.B.M.); Medical Research Institute, St. Petersburg, Russia (E.K.); Advanced Research for Health Improvement, Immokalee, FL (A.G.); Lung Center of the Philippines, Quezon City, Philippines (V.D.R.); Hospital Universitario La Paz, IdiPAZ, Madrid (A.M.-Q.); Clinical Pharmacology Unit, Hadassah–Hebrew...

Funder

Merck

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2116044

Cited by 1421 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model;Antiviral Research;2024-11

2. SARS-CoV-2 replication and drug discovery;Molecular and Cellular Probes;2024-10

3. Effectiveness and safety of molnupiravir in the intended-use population: an observational cohort study;Clinical Microbiology and Infection;2024-10

4. Nebulized inhalation of plasma-activated water in the treatment of progressive moderate COVID-19 patients with antiviral treatment failure: a randomized controlled pilot trial;BMC Infectious Diseases;2024-09-12

5. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control;Signal Transduction and Targeted Therapy;2024-09-11